Elevated concentrations of serum MMA among participants with decreased cognitive performance. حسب Yige Liu (11940344)

IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1. حسب Iratxe Zuazo-Gaztelu (21071939)

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. حسب Cristina Dolciotti (16317330)

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... حسب Robert Trybulski (10998702)

Middle cerebral artery mean flow velocity at three time points. حسب Marco Carbonara (11483575)

الموضوعات:

Most significant muscle activation values. حسب María Benito-de-Pedro (22057468)

الموضوعات:

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. حسب Katherine Schubert (5452712)

The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Maximum IFN concentrations are decreased in severe patients. حسب Sonia T. Gazeau (21512764)

Annual treatment frequencies in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Significant repeated measurements sEMG outcomes. حسب María Benito-de-Pedro (22057468)

الموضوعات:

Significant single measurement sEMG outcomes. حسب María Benito-de-Pedro (22057468)

الموضوعات:

Annual number of outpatient visits in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Cephalometric measurement points. حسب Lijuan Liu (136685)

الموضوعات:

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Time course of optical coherence tomography and fundus findings in a representative non-recurrent eye. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات: